Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ES135 / Eusol Biotech
NCT03229031: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury	Suspended	3	160	RoW	ES135	Eusol Biotech Co., Ltd.	Spinal Cord Injuries	12/24	12/26
NCT06328166: The Effect and Safety of Recombinant Fibroblast Growth Factor-1 for Carpal Tunnel Syndrome	Recruiting	N/A	28	RoW	Sono-guided injection with ES135, Sono-guided injection with placebo	Tri-Service General Hospital, Eusol Biotech Co., Ltd.	Carpal Tunnel Syndrome	05/25	05/25
diphenhydramine/lorazepam/zolpidem (SM-1) / Eusol Biotech
NCT03338764: An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia	Withdrawn	3	220	NA	SM-1, Placebo	Sequential Medicine Ltd	Transient Insomnia	12/23	12/23
NCT04396327: SM-1 vs. an Active Comparator in A Model of Transient Insomnia	Not yet recruiting	2	14	US	SM-1, Active Comparator	Sequential Medicine Ltd	Transient Insomnia	06/20	06/20

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ES135 / Eusol Biotech
NCT03229031: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury	Suspended	3	160	RoW	ES135	Eusol Biotech Co., Ltd.	Spinal Cord Injuries	12/24	12/26
NCT06328166: The Effect and Safety of Recombinant Fibroblast Growth Factor-1 for Carpal Tunnel Syndrome	Recruiting	N/A	28	RoW	Sono-guided injection with ES135, Sono-guided injection with placebo	Tri-Service General Hospital, Eusol Biotech Co., Ltd.	Carpal Tunnel Syndrome	05/25	05/25
diphenhydramine/lorazepam/zolpidem (SM-1) / Eusol Biotech
NCT03338764: An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia	Withdrawn	3	220	NA	SM-1, Placebo	Sequential Medicine Ltd	Transient Insomnia	12/23	12/23
NCT04396327: SM-1 vs. an Active Comparator in A Model of Transient Insomnia	Not yet recruiting	2	14	US	SM-1, Active Comparator	Sequential Medicine Ltd	Transient Insomnia	06/20	06/20